Previous 10 | Next 10 |
BOULDER, Colo., Sept. 26, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced that Chief Medical Officer Steve Williams, M.D., Ph.D., has been named a 2022 C-Suite Award winner by the Denver Business Journal. The honorees in t...
BOULDER, Colo., Sept. 14, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that management will be participating in the upcoming Capital One Spatial Biology & Proteomics Summit taking place virtually on Wednesday, September 28. ...
BOULDER, Colo., Aug. 31, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the upcoming Morgan Stanley 20th Annual Global Healthcare Conference in New York, New York. Roy Smythe, M.D, S...
SomaLogic, Inc. (SLGC) Q2 2022 Earnings Conference Call August 15, 2022 04:30 PM ET Company Participants Marissa Bych - IR, Gilmartin Group LLC Roy Smythe - Chief Executive Officer Shaun Blakeman - Chief Financial Officer Conference Call Participants ...
SomaLogic ( NASDAQ: SLGC ) stock tumbled 12% postmarket on Monday after the clinical diagnostics firm slashed its 2022 revenue guidance due to ongoing variability in core service business, macroeconomic and commercial factors. SLGC now expects 2022 revenue of $80M-$90M, wi...
SomaLogic press release ( NASDAQ: SLGC ): Q2 GAAP EPS of -$0.13 beats by $0.05 . Revenue of $14.1M (-28.7% Y/Y) misses by $10.72M . For further details see: SomaLogic GAAP EPS of -$0.13 beats by $0.05, revenue of $14.1M misses by $10.72M
Second quarter 2022 revenue of $14.1 million, bringing year to date revenue to $37.1 million. Reducing 2022 revenue guidance to $80-90 million to account for ongoing variability in core service business, macroeconomic and commercial factors. Maintaining substantial cas...
SomaLogic ( NASDAQ: SLGC ) to acquire Palamedrix, an innovator in DNA nanotechnology, that provides deep scientific and engineering expertise, miniaturization technology and enhanced ease-of-use capabilities that company intends to leverage as it develops the next gen...
Brings differentiated miniaturization technology, scientific and engineering expertise, and enhanced ease-of-use capabilities to SomaLogic’s platform while expanding footprint to San Diego, CA BOULDER, Colo. and SAN DIEGO, July 26, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ...
BOULDER, Colo. , July 25, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that it will report financial results for the second quarter 2022 after market close on Monday, August 15, 2022. Company management will host a corresponding...
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health , today announced that its stockholders voted to approve all proposals required to be approved in...
SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting PR Newswire Stockholder Approval Represents Key Milestone Toward Completion of Standard BioTools Transaction Combination Will Create a Diversified Leader in Life Sciences Tools ...
Believes All SomaLogic Directors – Robert Barchi , Thomas Carey , Eli Casdin , Troy Cox , Kathy Hibbs , Anne Margulies , Tycho Peterson , Richard Post and Jason Ryan – Have Betrayed Shareholders by Delaying the Special Meeting Five Times so the Bo...